6‐(2,6‐Dichlorobenzyl)‐5‐ethyl‐2‐(4‐methoxybenzylsulfanyl)pyrimidin‐4(3H)‐one
6‐(2,6‐Dichlorobenzyl)‐5‐ethyl‐2‐(4‐methoxybenzylsulfanyl)pyrimidin‐4(3H)‐one
复制标题
DOI:
10.1107/s1600536807034976
复制
发表时间:
2007-08
影响因子:
0.9
通讯作者:
Yueping Wang;Fen‐er Chen;Minqin Chen
中科院分区:
文献类型:
--
作者:
Yueping Wang;Fen‐er Chen;Minqin Chen
The title compound, C21H20Cl2N2O2S, was synthesized as a potential reverse transcriptase (RT) inhibitor of the human immunodeficiency virus type 1 (HIV-1). Structural analysis confirms that the compound is present in the 3H-tautomeric form. A centrosymmetric dimer is formed in the crystal structure through pairs of N—H⋯O hydrogen bonds. The structure also displays C—H⋯Cl and C—H⋯O interactions.